Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia
Apply
NRX 195183
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step